Close Menu

NEW YORK — Antibodies against SARS-CoV-2 did not decline among Icelandic patients in the four months following diagnosis, according to a new study from DeCode Genetics researchers.

Two recent studies had suggested that antibodies against SARS-CoV-2 might dwindle as patients recover from the disease, a finding that suggested immunity to the virus could be brief.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.